Results of a study examining the combinations of rituximab and bendmustine as well as cytarabine and rituximab followed by autologous stem cell transplant for treament of MCL.
Home / Resource Library / Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma